Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer
Status:
Completed
Trial end date:
2011-01-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the cumulative Maximum Tolerated Dose (MTD) and
Minimum Efficient Dose (MED) of BP-C1 in the short-term treatment of metastatic breast cancer
patients.
Phase:
Phase 1
Details
Lead Sponsor:
Meabco A/S
Collaborators:
Meddoc Meddoc Research Indonesia Ltd Meddoc Research Taiwan Ltd Norwegian University of Life Sciences